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Abstract 
Dieulafoy disease is an uncommon cause of gastrointestinal system bleeding. Although 
the exact cause is not known, it is characterized by bleeding from abnormal submucosal 
vessels. There are many methods for diagnosis and treatment. In this case, a patient with 
a long-time undiagnosed stomach Dieulafoy lesion had a surgical resection. During the 
postoperative period the patient was discharged without any complication. 
 
Case Report 
A 75-year-old woman with melena-like defecations over a three- to four-day period on a monthly 
basis had been evaluated at different hospitals for gastrointestinal system hemorrhage during a period of 
16 years. She had been given over 100 units of blood because of low hematocrit. The patient had been 
suffering from bronchial asthma for 46 years and had been using levothyroxine because of total 
thyroidectomy 15 years earlier. Her last upper gastrointestinal system endoscopy had shown an 
ulceration in 2 cm bouffant floor with vessels visible in the crater proximal to the corpoantral junction 
in the greater curvature between the piles. Physical examination was normal except for her melena at 
rectal examination. Blood pressure and pulse were stable. Hematocrit was 24.4% and hemoglobin 
7.77 g/dl. The erythrocyte sedimentation rate was 47 mm in the 1st hour (normal value 0–20 mm/h); 
gastrin was 124 pg/ml (normal value 0–150 pg/ml). After 5 units of blood transfusion, hematocrit was 
33.5% and hemoglobin 10.4 g/dl. Abdominal CT scans were normal, and her tentative diagnosis were 
arteriovenous malformation or gastrointestinal system stromal tumor. At exploration during surgery, 
there was no gross pathology or free fluid in the abdomen. Intraoperative gastroscopy showed a 
smooth-surfaced vascular lesion with a diameter of 1.5 cm located at the front surface of the corpoantral 
junction (fig. 1); a wedge resection was performed. Macroscopic examination revealed that there was a 
1 cm diameter, crater-shaped mucosal erosion lined by a vascular structure (fig. 2). After 
histopathologic examination, it was reported as a submucosal dilated, thrombotic vascular structure 
(fig. 3). The patient’s melena stopped and her hemoglobin and hematocrit values reverted to normal 
ranges. She was discharged healthy from hospital after the 5th postoperative day and re-examined 
during the 1st, 3rd and 6th months after discharge. During 7 months follow-up no recurrence of 
symptoms was detected.  
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Discussion 
Dieulafoy lesion was first described by Gallard in 1884 as ‘millier aneurysm of 
stomach’. At 1898 Dieulafoy described this as ‘l’exulceratio simple’. This encompasses 
approximately 4% of upper gastrointestinal system hemorrhage and can cause, for 
example, hematemesis, hemotochezia and melena. 
Dieulafoy lesion is seen infrequently and can result in life-threatening situations [1]. 
The lesion is generally seen in the stomach and especially within 6 cm of the 
gastroesophageal junction in the lesser curvature. It occurs at all ages but generally after 
the age of 60. Male gender is dominant. One third of cases occur outside the stomach, the 
duedonum and colon being commonly affected. The lesion can rupture spontaneously 
and without known cause, resulting in gross hemorrhage. The hemorrhage frequently 
comes from the submucosal eroded artery at the proximal stomach [2]. Endoscopy is used 
frequently in diagnosis, but unfortunately because of size and hidden location, diagnosis 
is difficult. The typical endoscopic view is of an artery that is located in a solitary, round 
mucosal defect [1]. There is no peripheral ulceration. Angiography may also be useful at 
diagnosis [2, 3]. 
The treatment modalities are various [4]. Endoscopic band ligation is prevalent [5]. 
Xavier et al. successfully performed band ligations in all Dieulafoy patients in their series 
[5]. Ertekin et al. also performed a band ligation in a 25-year-old woman with Dieulafoy 
lesion [6]. Parra-Blanco et al. used endoscopic hemoclips in their treatment of Dieulafoy 
lesion and stated that endoscopy must first be undertaken [7]. Alshumrani et al. treated a 
77-year-old man with endovascular embolisation [2]. Baettig et al. found that 20 patients 
(95%) treated with endoscopic norepinephrine and polidocanol for Dieulafoy 
hemorrhage had no recurrence [8]. Yilmaz et al. successfully treated 26 of 28 (92.8%) such 
patients by endoscopic injection sclerotherapy [9]. 
Surgery is an option for treatment: coagulation or vessel ligation, proximal gastric 
resection and wedge resection may be used. When using wedge resection, diagnosis may 
be confirmed with the help of pathologic-anatomic examination. In our case we chose 
curative surgery by wedge resection because there was chronic hemorrhaging lesion and 
the diagnosis was not certain. 
Conclusion 
Dieulafoy lesion is seen infrequently, may cause severe gastrointestinal system 
hemorrhage and can be difficult to diagnose. Endoscopy or surgery can be curative after 
diagnosis. 
 
 
 
 
  
Case Rep Gastroenterol 2008;2:469–473 
DOI: 10.1159/000175414 
Published online: November 19, 2008  © 2008 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
471
Fig. 1. Intraoperative illuminational view of Dieulafoy lesion. 
 
 
 
Fig. 2. Intraoperative illuminational view of Dieulafoy lesion. 
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Fig. 3. Microscopic view of Dieulafoy lesion. 
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